12 ms·
Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.
- cliff 7y agoIf you haven't read it, I highly recommend the book 'Bottle of Lies' which was released a few months ago. It details systemic corruption in a number of generic pharmaceutical manufacturers. It also details how the FDA is struggling with monitoring overseas manufacturing.
- vmurthy 7y agoI just came to write this :-). Here’s the link for anyone interested https://www.amazon.in/Bottle-Lies-Inside-Story-Generic-ebook/dp/B07JG49BQW https://www.amazon.in/Bottle-Lies-Inside-Story-Generic-ebook...
- KingMachiavelli 7y ago> By 2014, the FDA had closed its offices in Shanghai and Guangzhou, leaving only the Beijing office with inspectors who could visit Chinese factories on short notice. > The FDA checks less than 1% of drugs for impurities or potency before letting them into the country. For a regulator body who's job it is to make sure medical products are safe and available. These comments, if true, lend credability that the FDA is more regulatory capture than actual useful regulation. > The FDA’s relationship with manufacturers like Huahai, on the other hand, isn’t simple at all. If Huahai wants to make its own version of a generic drug and export it to the U.S., it needs FDA approval. But if Huahai supplies the main ingredient to a company that finishes the drug and sells it in the U.S., it’s required only to keep the FDA informed of any changes to the manufacturing process. Good, now you have a US company you can actually prosecute severely. The $/mass of phamacuticals means testing a small sample of each batch is super easy and if you know the manufacture process it's not hard to know what secondary products/contaiminents you need to test for. This is pure negligence on the FDA's and the US importers part. > “The only element who cares in this whole global supply chain is patients” Not if you actually fine the American importers into the ground. And ban the at fault over seas companies.
- fucking_tragedy 7y ago> These comments, if true, lend credability that the FDA is more regulatory capture than actual useful regulation. It lends more credibility to the fact that the FDA is notoriously underfunded when it comes to ensuring the safety of drugs[1]. [1] https://www.ncbi.nlm.nih.gov/books/NBK52926/ https://www.ncbi.nlm.nih.gov/books/NBK52926/
- deleted 7y ago[deleted]
- pessimizer 7y agoAn industry that sells drugs would want the regulating authority to be underfunded when it comes to insuring the safety of drugs.
- refurb 7y agoReally? Back when the FDA was underfunded in the 80s, there was a massive backlog in drug approvals that cost drug makers billions. They happily coughed up fees to better find the FDA.
- tmp190914pn2 7y agoUnderfunding certainly can(has?) interfere with their ability to do their job. But proper funding might not help if regulatory capture is also in play. I'm of the persuasion that governmental organisations need to be shaken up from time to time to prevent ossification, stagnation, inefficiencies, regulatory capture, ideological capture, etc... but the new agency needs to utilize the pieces from the old agency (not to start from scratch).
- lostmsu 7y ago>> The FDA checks less than 1% of drugs for impurities or potency before letting them into the country. > For a regulator body who's job it is to make sure medical products are safe and available. These comments, if true, lend credability that the FDA is more regulatory capture than actual useful regulation. I wonder though if this statement misrepresents the facts. If they check only 1% of the entire import volume at random, that is totally normal and what I'd expect them to do.
- knolax 7y ago> Some of the contaminated valsartan contains as much as 17 micrograms of NDMA in a single pill. That’s equivalent to eating 48 pounds of bacon. The FDA estimates that for every 8,000 people who took the highest dose of contaminated valsartan daily for four years, there would be one additional occurrence of cancer. Given the relatively small significance and the fact that this article was published in an issue with the blurb "Can You Trust Generics?" on the cover, I'm gonna say this is just more FUD from Bloomberg.
- fucking_tragedy 7y agoFor a blood pressure medication, 1 in 8,000 is not a small risk. Serzone, an antidepressant, has a similar risk rate for inducing liver failure, and was taken off the market.
- strainer 7y agoIt demonstrates a not insignificant risk but it would be from taking the most contaminated batch of the product for 4 years. If a patient took the most contaminated sample found for 4 years there would be a 1/8000 chance of cancer from it. It illustrates this level of contamination should be a concern but it seems unlikely anyone could be exposed continuously to this highest detected level.
- Scoundreller 7y agoFor nefazodone, we had other antidepressants (so why take the risk?), and it was only taken off the market when it went generic (lol). For BP medication, hopefully at least 1 in 100 recipients are benefitting from it. Probably more like 1 in 10. Overall, don't stop taking it. Reducing the cancer risk is possible and feasible in this case without changing therapy. We'll probably see further testing of APIs and validation of synthetic route changes in the future because of it.
- zkms 7y ago> Given the relatively small significance and the fact that this article was published in an issue with the blurb "Can You Trust Generics?" on the cover, I'm gonna say this is just more FUD from Bloomberg. It's not a small significance, and it's not FUD. It's admittedly possible to take some measured numbers for the prevalence of one of the nitrosamines, put that through a dose-response model (of controversial accuracy) and come up with low-sounding numbers of expected cancers, but that's not enough to dismiss the issue. Nitrosamines are notorious carcinogens, the side-reactions that produced them is well-known (if this comment (https://blogs.sciencemag.org/pipeline/archives/2019/01/04/the-sartan-contamination-story#comment-299170 https://blogs.sciencemag.org/pipeline/archives/2019/01/04/th...) is to be believed, known since the 1930s), and detecting these genotoxic impurities is feasible without exotic analytical equipment. The mechanics of the synthesis routes should never have allowed production of those impurities, the active pharmaceutical ingredient should have been monitored for these impurities as well, and this aberration should have been discovered far earlier than it actually was. It's a lot like foreign object debris in aircraft, or retained surgical instruments inside a patient. Neither are a guaranteed death sentence, but they're harmful, utterly avoidable, and their prevalence is a good indicator of careless/inappropriate working practices and inadequate monitoring procedures. If their procedures couldn't detect these nitrosamines for years -- what else is being let through? Heavy metals? Pyrogens? Some other class of toxic chemicals? Inadequate/overly-high active ingredient dose/concentration? I've installed avionics inside other people's aircraft and I was careful to not leave behind any tools / bits of wire insulation / snipped-off wires / screws / etc floating around. Yes, the probability that a single bit of wire will find its way onto uninsulated connectors is small, but that argument is not an excuse for sloppy working methods. With life-critical systems, it's not OK to be careless just because someone else might catch the problem or because there's other subsystems that'll attenuate the severity of the fault.
- JMTQp8lwXL 7y agoI wonder if the point of this, is to have us weigh getting "brand name" more seriously. There is no sensible reason to pay a premium for brand name if the generic is chemically equivalent.
- gwbas1c 7y agoYes there is. It's primarily based around different characteristics of how the medication dissolves in the patient's stomach, or the differences between fillers and binders.
- MegaButts 7y agoDoesn't that mean they're not chemically equivalent?
- mikeyouse 7y agoThe active ingredient is the same - the binders and fillers and capsule materials are mostly inert. This isn't true for all drugs - for the blood thinner Coumadin, you're meant to stick to generic or brand name and not switch between the two since there are known differences in efficacy.
- MegaButts 7y agoI understand that. OP said: > There is no sensible reason to pay a premium for brand name if the generic is chemically equivalent. If they're not chemically equivalent and have different medicinal effects as a result, then it's much easier to justify a price difference. I understand chemistry is more than just a list of ingredients. It's how those ingredients are combined that gives them their unique interactions.
- JMTQp8lwXL 7y agoFor sake of the discussion here, bio-equivalence is the more helpful way for meaningfully comparing generic to brand names. The filler might be different, but if the biological effect is identical at half the cost, one would be prudent to chose the generic option.
- pkaye 7y agoAre these problems only limited to the US? Do Canada or the EU have similar issues? Do they not import chemicals from similar suppliers or do they screen the better?
- refurb 7y agoIt's an issue in Canada[1] and the EU[2]. [1]https://www.bcpharmacists.org/news/update-august-18-2018-drugs-containing-valsartan-being-recalled-due-contamination-potential https://www.bcpharmacists.org/news/update-august-18-2018-dru... [2]https://www.ema.europa.eu/en/medicines/human/referrals/angiotensin-ii-receptor-antagonists-sartans-containing-tetrazole-group https://www.ema.europa.eu/en/medicines/human/referrals/angio...
- braindead_in 7y agoWhat about India? Are Indian generics affected as well?
- AstralStorm 7y agoVery likely too, including other issues previously found I'd expect anything to happen there.
- sjg007 7y agoIt's an issue everywhere. Almost all generics are manufactured in India and China. And most with Chinese precursors.
- pkaye 7y agoYeah but the article and some others are making it seem like something unique to the FDA. It seems to be a global issue and they all need to improve their quality control and testing processes.
- s1artibartfast 7y ago
- neonate 7y agohttp://archive.is/VN1hl http://archive.is/VN1hl
- newsreview1 7y agoThanks
- armitron 7y agoNow imagine what level of contamination is going on in supplements which are completely unregulated in the US (unlike the EU).
- aresant 7y agoI would pay good money for a supply chain based “consumer reports” so I actually know what’s in my products eg - medicines! - supplements - food - clothing Clearly in the USA their is gigantic demand for organic / harmful chemical free products.
- devoply 7y agoSeems like a good differentiator for a retailer... Maybe online only retailer. Maybe someone like Walmart trying to compete with Amazon.
- ceejayoz 7y agoAmazon (ironically enough, given their counterfeiting problems) has been doing this for their Elements supplement brand. Example: https://www.amazon.com/Amazon-Elements-Multivitamin-Cultured-Tablets/dp/B075DLLC4S https://www.amazon.com/Amazon-Elements-Multivitamin-Cultured... You can scan a QR code and get the test results for the specific batch included in the bottle.
- refurb 7y agoThe article talks about a pharmacy that does just that - tests all the products before dispensing them and rejecting those that don't pass.
- azinman2 7y agoThis could be an interesting case for blockchains. I normally am not a proponent of seeing everything thru that lens, but having a proper chain that is publicly verifiable is in the public’s interest. That said, there’s not a lot of incentive for people to reveal their supply chains — it’s often trade secret or hidden for a reason. If there was a market behind it, then there might be a way. But good luck getting Samsung to tell you where their cobalt came from, or if some generic drug was made in a dangerous lab. Even if you knew it was Generic Factory 1736, it’s hard to know if that’s good or bad.
- BlueGh0st 7y ago
- wtvanhest 7y agoQuick question. Title says "generic", but obviously there is a massive economic interest in switching people from generics to non-generics. Is this contamination also possible in non-generics???
- copperx 7y agoSure, it is possible, but because the brand name passed the carcinogenicity tests in animals, and if the manufacturer kept their same suppliers and formulation, the risk should be much lower. Whether that's true or not in practice is a different matter. But yes, I would have more confidence in a brand name after this report, which makes me cynical about the intentions of the reporting in the first place. Maybe I'm totally being manipulated by big pharma, but I'll switch my medication to brand name as soon as possible, and that's just because my insurance is good. Very few people have that option.
- gus_massa 7y ago> the brand name passed the carcinogenicity tests in animals, and if the manufacturer kept their same suppliers and formulation I really doubt this is the common case. The studies with animals and the clinical studies with human for safety are very small, so I guess they use a special batch. For production at scale they probably use some industrial method that is cheaper. They may also change the provider, or build it in another factory they own in other country. Also, every drug has precursors, and has precursors have precursors, you can't produce all of them so you must buy some. And with many of them there are more possibilities of changes that introduce contamination. What you get with a brand name is more quality control in the incoming products, more quality control in the process and more quality control in the final product. (And also more marketing, sometimes it is only marketing.)
- Scoundreller 7y agoThe problem is that big pharma can (and do!) change their chemical synthesis process for its APIs. Without going through all the same testing again.
- jessaustin 7y ago
- coreyoconnor 7y agoGood to know that the US health care system will impose these individuals with the cost. Shame on them for not properly researching the product. They should have considered their consumer choices against the possibility of cancer years later. No doubt the medical bankruptcy some will have is deserved. Obviously sarcasm. This is, however, how the current US medical system behaves. It's impossible that these patients would have the capacity to evaluate medication sources like they would any other product. Many likely had no opportunity or choice. Yet the US supports a system that punishes an individual for aspects well beyond the individual.
- sjg007 7y agoYou should able to sue the pharmacy and your insurer for sourcing and requiring tainted products that are not quality controlled. I would expect some class action lawsuits to appear shortly.
- ridgeguy 7y agoI hope so. After reading the Bloomberg article, I looked up my Losartan Rx. It's from a manufacturer's lot that was pulled by the FDA on Feb 28 of this year. The kicker is, my (major chain) pharmacy sold it to me this July...
- sjg007 7y agoI would get a lawyer. Sounds like you are due a nice settlement.
- coreyoconnor 7y agoIdeally yes. However, that's assuming a lot of privilege that the average consumer wouldn't have at all in this case.
- newsreview1 7y agoWow, to formulate a generic drug and export it to the U.S. requires the FDA stamp, but if you generate components used in manufacture of US-made drugs get literally no FDA oversight. How can this be?.
- opencl 7y agoIn principle the FDA should inspect the US-made drug after manufacture so inspecting all of their suppliers would be redundant.
- rjf72 7y agoFor what it's worth many things are like this. It's the same thing with genetically engineered products, also under FDA purview. There is 0 mandatory oversight. If you have the clearance to sell a potato, then you can produce any engineered potato you like and sell it with 0 oversight, testing, or additional requirements. All the FDA offers is a purely voluntary opt-in consultation. [1] Perhaps unsurprisingly this [2] was the head of the FDA under our last president. He was appointed a newly created executive role, not entirely jokingly referenced as the 'czar of foods.' A Monsanto vice president and lobbyist whose career highlights included arguing that companies should be allowed to knowingly allow at least a very small amount of carcinogenic chemicals into foodstuffs. Seriously, that was the head of the US Food and Drug Administration for nearly 8 years. [1] - https://www.fda.gov/food/food-new-plant-varieties/how-fda-regulates-food-genetically-engineered-plants https://www.fda.gov/food/food-new-plant-varieties/how-fda-re... [2] - https://en.wikipedia.org/wiki/Michael_R._Taylor https://en.wikipedia.org/wiki/Michael_R._Taylor
- healththrow3 7y agoI made this account to respond to exactly this question. The FDA's legal basis to regulate medicines is actually incredibly weak and really hasn't changed much since the 1930s. One of the examples is exactly this case. The FDA only regulates finished medicines in two cases a) brand name or b) generic equivalents. Leaving aside brand name drugs for the moment getting approval to sell a generic equivalent doesn't look anything like what you would expect. What people generally think is that generic drugs are 'copies' of existing brand name drugs and the FDA cares about making sure the generic guys are producing the same drug as the brand name one. This isn't what happens at all. A manufacturer has to demonstrate similar blood level uptake as the FDA approved equivalent drug using a very similar approval process for the brand name drug. This requires an incredible effort that is substantially the same as getting an original drug approved. The bottom line is that the FDA doesn't examine the on-going manufacturing of the drug much or supplier reliability much at all. If a manufacturer can pass blood level equivalence nothing else really matters. This equivalence is only valid for the direct manufacturting producer of the drug, not the company marketing it. The reality is that if you want to get FDA approval for a generic you might as well partner with a firm outside the US that knows how to handle this process because its a waste of money jumping through FDA hoops to certify a new facility in the US. Once you have proved equivalance you can start selling the drug. At this point, the FDA is basically done. The FDA basically dones't care anymore and has very weak sanctions to enforce safety compliance. The FDA can't do anything about this situation on its own; the way drugs are approved is directly established by law that dates back to the 1930s. I notice a lot of people in this thread suggesting that FDA leadership is bought off and does the work of the drugs companies. I assure you this is not the case. FDA oversight of pharmacutecial ingredients is accomplished under an entirely different legal regime that has nothing to do with drug approval whatsoever.
- test43 7y agoPharmacy Mafia
- stock_toaster 7y agoApparently NDMA has also been found in Zantac (ranitidine), a common OTC heartburn medicine. The FDA has issued an alert - https://www.fda.gov/safety/medwatch-safety-alerts-human-medical-products/zantac-ranitidine-safety-information-ndma-found-samples-some-ranitidine-medicines https://www.fda.gov/safety/medwatch-safety-alerts-human-medi...
- azinman2 7y agoThey offer that but little additional information. Is it just Zantac the commercial brand? How do I know if I’m affected?
- stock_toaster 7y agoNot sure. It is indeed pretty alarming! I take it every day (and have for years) for GERD! :/ Guess I'll try switching to something else and see how it goes.
- el_benhameen 7y agoNot an ad, just my experience: I googled the company, Valisure, that was mentioned in this article and another in the NYT. In addition to selling drugs that they've tested, they'll also take a sample and test your own prescriptions. Price is $40 for their "impurities/carcinogen" analysis. Worry may well be overblown at this point, but my kid was prescribed ranitidine and some peace of mind is worth 40 bucks to me.
- cooljacob204 7y agoAnd I would have never learned about this unless I was surfing hacker news. Bleh. From the NDMA wiki: [NDMA] is also used to create cancer in rats for cancer research. That is super alarming.
- el_benhameen 7y agoYep. Just happened to see this [1] article out of the corner of my eye while browsing. Really concerning. And from the sound of it, this Valisure place, not the FDA, is the one who discovered the issue. One wonders what use regulators are these days. My infant daughter was prescribed ranitidine for reflux from age 3 months to about age 6 months. Anyone with more chemistry knowledge than me want to venture any guesses about how concerned I should be? [1]https://www.nytimes.com/2019/09/13/health/zantac-cancer-ndma.html https://www.nytimes.com/2019/09/13/health/zantac-cancer-ndma...
- dghughes 7y agoAdding to this some people may not know unlike here in Canada supplements in the US are not regulated. Herein Canada they are treated as a drug and regulated by Health Canada. There have been recalls of supplements from the US due to contamination or mislabeling (for example, adding stimulants or steroids but not disclosing that). Although supplements here in Canada can still be questionable in quality.
- AstralStorm 7y agoTechnically FDA handles supplements and foods too, but they're really too small to handle the volume of this market.
- froasty 7y agoReally? It's 2019, there is no argument to be had over this. Impurity problems have occasionally come up over the years, but they have largely been addressed quickly by existing regulations. And at no point have they ever approached the level of risk posed by the illnesses they are prescribed to treat. While the risk of impurities in the generic drug supply certainly warrant research, the percentage of issues again doesn't approach significance with comparison to these pervasive illnesses. Nothing is risk-free. Eating food has risk, taking paracetamol has risk, getting blood drawn has risk. Saying something has risk without talking about the amount of risk and the context of the risks it mitigates is pointless. Drug impurities in generics introduce negligible amounts of risk. Eating peanuts in public or going for a drive is much riskier, and we almost all do those things without a second thought. By contrast, access to affordable drugs mitigate huge risks: the illnesses we medicate can, did and do cause horrific harm up to and including death, and do so very well. The pharmaceutical industry is not immune to criticism, it is just they have weathered all the reasonable criticism leveled at them. If you are willing to drive in a car, taking generics that could should be a complete non-issue for you. In an era of fake news and increasing doubt in the medical establishment, publishing reports like this is not only irresponsible, but unethical. This only adds fuel to the fire of unwarranted skepticism towards our medical system.
- brianpgordon 7y agoI thought the article did a decent job of explaining exactly what the problem is in this case and communicating the scale of the risk. Your comment, on the other hand, sounds like a kneejerk dismissal entirely based on the headline not agreeing with what you thought was true. Yes generics have proven to be broadly safe. That doesn't mean there aren't still issues that need to be addressed by tweaking or adding regulation. Yes even with carcinogens the contaminated generics are probably better than taking nothing. That doesn't mean that the contamination is acceptable.
- KingMachiavelli 7y agoExactly, I sort of failed to highlight this directly in my comment but the fact that the article focuses on a single case of tainted generics vs who knows how many people die each year waiting for drugs to be approved and/or imported is pretty insane.
- robocat 7y agoThe solution is to have three classes of quality for every drug: lower class, middle class, and upper class. The lower class drugs must have pills with Chinese characters on them, and packaging with Chinese writing, and an English insert. They get minimal testing. The upper class pills have American flags impressed on them, cost a metric tonne more, but are tested rigorously by private agencies (that are paid from the extra cost). The aim here is propoganda: have people associate poor quality with Chinese goods and good quality with American goods. (There is no middle class of drugs: if you are a middle earner you either decide to be either cheap, or to keep up appearances).
- copperx 7y ago> have people associate poor quality with Chinese goods Nobody is going to associate poor quality with Chinese goods while iPhones and most luxury continue to be made in China. > keep up appearances Nobody should know what drugs I'm on, much less the brand I take.
- dqpb 7y agoWelcome to the future of warfare.
- bg24 7y agoThis deserves many more upvotes. External agents find cheap ways to destroy the country, and some internal agents sacrifice common man for quarterly bonus. A virally popular device (non-prescription and cheap, for god’s sake) to detect toxicity levels, and connected app to visualize the health impact will serve as a wake-up call.
- president 7y agoCompletely agree. You'd think that when something like this happens, it would be followed up by a string of arrests. There is a total lack of accountability in this country. This country is totally corrupted.
- dqpb 7y agohttps://info.publicintelligence.net/USASOC-CounterUnconventionalWarfare.pdf https://info.publicintelligence.net/USASOC-CounterUnconventi...
- perl4ever 7y agoMost of the gardening implements, and most of the cheap shower heads in my local home improvement store say they cause cancer. I assume people buy them anyway, or the store would stock something else. So are these drugs with carcinogens of more concern than the other stuff? Should we be more concerned about the other stuff?
- wil421 7y agoAll of my fishing weights and some lures have these warnings. It’s because of lead. I certainly don’t put them in my mouth and neither should you. Shower heads are very concerning. Never seen those warnings.
- perl4ever 7y agoLead isn't particularly known as a carcinogen, but a neurotoxin. I guess it might be, but is it "known to the state of California"? The things I noticed that almost all had California warnings were shovels, rakes, etc. I don't really know why these would need to have lead in them, if that's what it was. I did buy a shower head, and I did buy one without the warning. But, I also thought - maybe this one has as much or more carcinogens as the cheap ones, but it doesn't have a label simply because it's not sold in California?
- Scoundreller 7y agoProbably the best source of information is from this long-time blogging Medicinal Chemist here: https://blogs.sciencemag.org/pipeline/archives/2019/01/04/the-sartan-contamination-story https://blogs.sciencemag.org/pipeline/archives/2019/01/04/th... This story has some speculation about why different molecules of the same therapeutic category are implicated: https://www.gmp-compliance.org/gmp-news/valsartan-what-caused-the-contamination https://www.gmp-compliance.org/gmp-news/valsartan-what-cause...
- userbinator 7y agoFrom the Wikipedia page https://en.wikipedia.org/wiki/N-Nitrosodimethylamine https://en.wikipedia.org/wiki/N-Nitrosodimethylamine "NDMA is a yellow, oily liquid with a faint, characteristic odor and a sweet taste." "characteristic" doesn't say much, but I often wonder how we know about the taste of a highly toxic chemical like this one --- and if someone died for it.
- AstralStorm 7y agoYou wouldn't taste it in a drug. Low concentrations and bound in binders or hidden by taste additives in syrups. Typically researchers tasted small samples, not too risky. Usually characteristic has a specific chemical kind of taste. Yes, people have tasted solvents, glue and more nasty stuff.
- Madmallard 7y agoDon't get generic drugs unless you absolutely have to. You are legally unable to sue if you get life altering side effects from the drugs. Which seems even worse after this news story.
- RachelF 7y agoThis whole episode of "self regulation" of pharma companies by the FDA reminds my of the FAA's acceptance of Boeing's "self regulation" on the 737 MAX.
- temptemptemp111 7y agoSays (((Bloomberg))) and the (((opioid pushers)))...
- say_it_as_it_is 7y agoToo many Bloomberg articles make it to the front page of Hacker News and that is unfortunate because Bloomberg is corporate media at its most diabolical. Bloomberg has a long history of publishing articles to earn moral credit and then cashing out on that credit from time to time with articles that clearly favor a small group of special corporate interests. Today, the story is that generics are harmful and cause cancer -- we better pay 20x for those name brands. Before, there were unsubstantiated claims about microprocessors used by Apple that were spiked with surveillance hardware: https://www.bloomberg.com/news/features/2018-10-04/the-big-hack-how-china-used-a-tiny-chip-to-infiltrate-america-s-top-companies https://www.bloomberg.com/news/features/2018-10-04/the-big-h... Don't be a Bloomberg shill. Ask yourself when you see an article published by Bloomberg who they are really serving with these stories. This comment was downvoted in about 5 seconds from when it was published. This was a comment at the bottom of a comment thread. There is no way for that to have happened other than by a bot. Bloomberg uses third party-controlled bots on HN to control the discussion. Sad.